Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.

Saved in:
Bibliographic Details
Main Authors Dager Indu, Sreenu Jennepalli, De Dibyendu, Baruah Anima, Khanna Ish Kumar, Pillarisetti Sivaram, Maitra Santanu, Alexander Christopher W, Alikunju Shanavas
Format Patent
LanguageEnglish
Published 10.10.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.
Bibliography:Application Number: US201514687467